Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor

Influenza virus neuraminidase (NA) drug resistance is one of the challenges to preparedness against epidemic and pandemic influenza virus infections. NA N1- and N2-containing influenza viruses are the primary cause of seasonal epidemics and past pandemics. The structural and functional basis underly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Wu, Yan, Gao, Feng, Qi, Jianxun, Bi, Yuhai, Fu, Lifeng, Mohan, Sankar, Chen, Yuhang, Li, Xuebing, Pinto, B. Mario, Vavricka, Christopher J., Tien, Po, Gao, George F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5110174/
https://ncbi.nlm.nih.gov/pubmed/27654293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01703-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars